| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5be9456a74cc707cc9ad4370982a402 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01008 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-18 |
| filingDate |
2015-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79f15b068e08b5a5d27ea9b60f4128c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662258be5a0ab3ee0909452e2b38ccb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb77f55a9a8299f9c0b2a46287164f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492e8641414f296c5b91855e1514f72b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b5bf7624b97c852dffced1d473f74b |
| publicationDate |
2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015197735-A1 |
| titleOfInvention |
7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| abstract |
New highly functionalizable Huprine derivatives of formula I: n n n n n n n n n n andn na method for preparing such compounds and their use for treating neurological diseases in which the level of acetylcholine is affected such as Alzheimer's disease. |
| priorityDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |